Centro de Endocrinologia y Nutricion

Caguas 00725

1 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Diseases, Chronic Kidney Disease, Diabetes, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes — Recruiting now
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight — Completed
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus — Completed